Literature DB >> 20637940

Molecular biology of liver ischemia/reperfusion injury: established mechanisms and recent advancements.

John R Klune1, Allan Tsung.   

Abstract

Hepatic ischemia/reperfusion (I/R) injury occurs in a variety of clinical contexts, including transplantation, liver resection surgery, trauma, and hypovolemic shock. The mechanism of organ damage after I/R has been studied extensively and consists of complex interactions of multiple inflammatory pathways. The major contributors to I/R injury include production of reactive oxygen species, release of proinflammatory cytokines and chemokines, and activation of immune cells to promote inflammation and tissue damage. Recent research has focused on the mechanisms by which these immune responses are initially activated through signaling molecules and their cellular receptors. Thorough understanding of the pathophysiology of liver I/R may yield novel therapeutic strategies to reduce I/R injury and lead to improved clinical outcomes. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20637940     DOI: 10.1016/j.suc.2010.04.003

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  81 in total

1.  Computational Analysis Supports IL-17A as a Central Driver of Neutrophil Extracellular Trap-Mediated Injury in Liver Ischemia Reperfusion.

Authors:  Samer Tohme; Hamza O Yazdani; Vikas Sud; Patricia Loughran; Hai Huang; Ruben Zamora; Richard L Simmons; Yoram Vodovotz; Allan Tsung
Journal:  J Immunol       Date:  2018-11-30       Impact factor: 5.422

2.  Serial volumetric assessment of large for size liver grafts after whole cadaveric liver transplant in adults: do large liver grafts shrink in size?

Authors:  Mohamed Bekheit; Muthukumarassamy Rajakannu; Petru Bucur; Rene Adam; Antonio SaCunha; Denis Castaing; Daniel Cherqui; Eric Vibert
Journal:  HPB (Oxford)       Date:  2015-11-28       Impact factor: 3.647

Review 3.  Sterile inflammation in acute liver injury: myth or mystery?

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015       Impact factor: 3.869

4.  Extended Ischemia Times Promote Risk of HCC Recurrence in Liver Transplant Patients.

Authors:  Arno Kornberg; Ulrike Witt; Jennifer Kornberg; Helmut Friess; Katharina Thrum
Journal:  Dig Dis Sci       Date:  2015-01-29       Impact factor: 3.199

5.  Does hepatic ischemia-reperfusion injury induced by hepatic pedicle clamping affect survival after partial hepatectomy for hepatocellular carcinoma?

Authors:  Feng Xia; Wan-Yee Lau; Yanmin Xu; Lin Wu; Cheng Qian; Ping Bie
Journal:  World J Surg       Date:  2013-01       Impact factor: 3.352

Review 6.  Regulation of drug-metabolizing enzymes by local and systemic liver injuries.

Authors:  Yan Guo; Bingfang Hu; Yang Xie; Timothy R Billiar; Jason L Sperry; Min Huang; Wen Xie
Journal:  Expert Opin Drug Metab Toxicol       Date:  2016-01-28       Impact factor: 4.481

7.  Blocking cold-inducible RNA-binding protein protects liver from ischemia-reperfusion injury.

Authors:  Andrew Godwin; Weng-Lang Yang; Archna Sharma; Adam Khader; Zhimin Wang; Fangming Zhang; Jeffrey Nicastro; Gene F Coppa; Ping Wang
Journal:  Shock       Date:  2015-01       Impact factor: 3.454

8.  5'-Methylthioadenosine attenuates ischemia reperfusion injury after liver transplantation in rats.

Authors:  Yong Tang; Weikang Zhang; Yu Zhang; Wenjing Wang; Feng Yao; Jiaqi Yan; Chidan Wan
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

9.  N-acetylcysteine administration does not improve patient outcome after liver resection.

Authors:  Stuart M Robinson; Rehan Saif; Gourab Sen; Jeremy J French; Bryon C Jaques; Richard M Charnley; Derek M Manas; Steven A White
Journal:  HPB (Oxford)       Date:  2013-01-07       Impact factor: 3.647

10.  Hydroxysafflor yellow A attenuates ischemia/reperfusion-induced liver injury by suppressing macrophage activation.

Authors:  Shujun Jiang; Zhen Shi; Changyong Li; Chunlei Ma; Xianyong Bai; Chaoyun Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.